Osteopontin (OPN) is a secreted protein present in bodily fluids and tissues. It is subject to
multiple post‐translational modifications, including phosphorylation, glycosylation …

Osteopontin (OPN) is a matricellular protein that binds to a number of cell surface receptors
including integrins and CD44. It is expressed in many tissues and secreted into body fluids …

We developed a novel detection method for osteopontin (OPN), a new biomarker for
prostate cancer, by attaching a genetically engineered single-chain variable fragment (scFv) …

A DNA aptamer with affinity and specificity for human osteopontin (OPN), a potential breast
cancer biomarker, was selected using the SELEX process, considering its homology rate …

Osteopontin (OPN) is involved in almost all steps of cancer development, and it is being
investigated as a potential biomarker for a diagnosis and prognosis of prostate cancer. Here …

Osteopontin (OPN) is a multifunctional protein present in most tissues and body fluids, with
the highest concentrations found in milk. Processes for isolation of OPN from bovine milk for …

Background: High plasma osteopontin (OPN) has been linked to tumour hypoxia,
metastasis, and poor prognosis. This study aims to assess whether plasma osteopontin was …

Mesothelioma is an aggressive cancer of pleural and peritoneal cells that is difficult to
diagnose and monitor. Numerous studies have attempted to identify a blood-or pleural fluid …

Human osteopontin (hOPN) is a secreted plasma protein which is elevated in various
cancers and is indicative of poor prognosis. Here we describe investigations involving an …

Background Therapeutic resistance to radiotherapy is one of the major obstacles in clinical
practice that significantly affect the therapeutic efficiency and prognosis of human …